盘旋 发表于 2025-3-23 11:33:25

Submitted on: 03 October 2018.
Revised on: 08 December 2018.
Accepted on: 19 January 2019.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

BOON 发表于 2025-3-23 16:31:45

http://reply.papertrans.cn/1/47/4676/4676-12.png

详细目录 发表于 2025-3-23 19:13:20

http://reply.papertrans.cn/1/47/4676/4676-13.png

雕镂 发表于 2025-3-23 22:58:07

http://reply.papertrans.cn/1/47/4676/4676-14.png

Reverie 发表于 2025-3-24 04:21:44

http://reply.papertrans.cn/1/47/4676/4676-15.png

Magnitude 发表于 2025-3-24 08:37:10

http://reply.papertrans.cn/1/47/4676/4676-16.png

CRACY 发表于 2025-3-24 11:50:49

Submitted on: 24 August 2006.
Revised on: 21 October 2006.
Accepted on: 27 November 2006.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

激怒 发表于 2025-3-24 17:36:10

Submitted on: 21 July 2008.
Revised on: 18 September 2008.
Accepted on: 15 November 2008.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

冒失 发表于 2025-3-24 19:43:43

http://reply.papertrans.cn/1/47/4676/4676-19.png

photophobia 发表于 2025-3-25 01:29:02

Submitted on: 01 April 2009.
Revised on: 20 May 2009.
Accepted on: 13 July 2009.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY
页: 1 [2] 3 4
查看完整版本: SCIE期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY 2024/2025影响因子:2.771 (CANCER CHEMOTH PHARM) (0344-5704). (ONCOLOGY)(肿瘤学)Scien